Add to ORKGBackground: The effectiveness of oral propafenone in converting recent-onset atrial f ibri l lation to sinus rhythm has been established by controlled trials. However, it is not clear whether the effectiveness of propafenone is affected by the presence or absence of underlying heart disease. Objectives: To investigate the safety and effectiveness of oral propafenone and the role of underlying heart disease
<p>Aim. To assess propafenone antiarrhythmic efficacy and optimal timing of the drug administration ...
Fourteen patients with atrial fibrillation or flutter and a ventricular rate of ≥120 beats/min occur...
Atrial fibrillation is the most frequent cardiac rhythm disturbance, with prevalence increasing with...
Background: The effectiveness of oral propafenone in converting recent-onset atrial fibrillation to ...
Objective -The aim of this study was to investigate the efficacy and safety of propafenone in the pr...
Background: Propafenone has been claimed to be effective in converting atrial fibrillation and flutt...
We have investigated the relationship of clinical variables to successful cardioversion of atrial fi...
Study objective: To compare placebo vs two different regimens of propafenone administration-intraven...
The efficacy and safety of propafenone as an oral loading dose (600-mg single oral dose) in converti...
A population of 105 patients with recent onset (<72 h) atrial fibrillation was randomly treated with...
Eighty-seven patients with recent onset atrial fibrillation (less-than-or-equal-to 8 days) without c...
Atrial fibrillation (AF) is a very common arrhythmia. In order to treat acute AF rapidly, effective ...
Propafenone, a new antiarrhythmic agent, was utilized in 30 patients with diverse heart disease who ...
A population of 105 patients (pts) with recent onset (<72 hours) atrial fibrillation (AF) without...
Propafenone is a potent antiarrhythmic agent effective in either supraventricular or ventricular tac...
<p>Aim. To assess propafenone antiarrhythmic efficacy and optimal timing of the drug administration ...
Fourteen patients with atrial fibrillation or flutter and a ventricular rate of ≥120 beats/min occur...
Atrial fibrillation is the most frequent cardiac rhythm disturbance, with prevalence increasing with...
Background: The effectiveness of oral propafenone in converting recent-onset atrial fibrillation to ...
Objective -The aim of this study was to investigate the efficacy and safety of propafenone in the pr...
Background: Propafenone has been claimed to be effective in converting atrial fibrillation and flutt...
We have investigated the relationship of clinical variables to successful cardioversion of atrial fi...
Study objective: To compare placebo vs two different regimens of propafenone administration-intraven...
The efficacy and safety of propafenone as an oral loading dose (600-mg single oral dose) in converti...
A population of 105 patients with recent onset (<72 h) atrial fibrillation was randomly treated with...
Eighty-seven patients with recent onset atrial fibrillation (less-than-or-equal-to 8 days) without c...
Atrial fibrillation (AF) is a very common arrhythmia. In order to treat acute AF rapidly, effective ...
Propafenone, a new antiarrhythmic agent, was utilized in 30 patients with diverse heart disease who ...
A population of 105 patients (pts) with recent onset (<72 hours) atrial fibrillation (AF) without...
Propafenone is a potent antiarrhythmic agent effective in either supraventricular or ventricular tac...
<p>Aim. To assess propafenone antiarrhythmic efficacy and optimal timing of the drug administration ...
Fourteen patients with atrial fibrillation or flutter and a ventricular rate of ≥120 beats/min occur...
Atrial fibrillation is the most frequent cardiac rhythm disturbance, with prevalence increasing with...